# Antibiotic Mechanisms & Coverage (USMLE)

> How do antibiotics work and what does each class cover on USMLE?

Every antibiotic class mapped to its mechanism, its gram-positive, gram-negative and anaerobic coverage, and the toxicity the vignette is really testing.

Antibiotics work by five mechanisms: blocking cell wall synthesis, inhibiting protein synthesis at the 30S or 50S ribosome, blocking DNA or RNA synthesis, disrupting the cell membrane, and inhibiting folate metabolism. On USMLE questions, each class maps to a predictable coverage profile across gram-positive, gram-negative, anaerobic, and atypical organisms.

## How do antibiotics work and what does each class cover on USMLE?

Exam items rarely test mechanism alone: a vignette names an organism and asks which drug kills it, or which toxicity follows. Study the triplet: **mechanism -> spectrum -> toxicity**.

Start from the wall. Gram-positive organisms have thick peptidoglycan and no outer membrane, which is why vancomycin works on them and never on gram-negatives, whose LPS membrane blocks entry and concentrates beta-lactamases in the periplasm. Review [gram-positive vs gram-negative bacteria](/blog/gram-positive-vs-gram-negative-bacteria-usmle) first, because coverage largely follows wall architecture.

| Class | Mechanism | Gram-positive | Gram-negative | Anaerobes | Classic use |
| --- | --- | --- | --- | --- | --- |
| Penicillin G/V | Blocks PBP cross-linking | Strep | Neisseria | Oral, Clostridium | Syphilis |
| Aminopenicillins | Same, porin entry | Strep, enterococci | HHELPSS | Oral only | Listeria |
| Nafcillin, oxacillin | Penicillinase-stable | MSSA, strep | None | None | Cellulitis |
| Pip-tazo | Same plus inhibitor | Broad | Broad, Pseudomonas | Both sides | Intra-abdominal |
| Cephalosporins 1-2 | Same | Broad, not MRSA | PEcK, HENS | Cefoxitin, cefotetan | Prophylaxis |
| Cephalosporins 3-5 | Same | MRSA if ceftaroline | Broad; Pseudomonas if ceftazidime | Limited | Meningitis |
| Carbapenems | Beta-lactamase stable | Broad, not MRSA | Broadest | Yes | ESBL sepsis |
| Vancomycin | Binds D-Ala-D-Ala | Broad, MRSA | None | C. difficile, oral | Bacteremia |
| Aminoglycosides | Irreversible 30S | Synergy only | Strong, Pseudomonas | None | Sepsis synergy |
| Tetracyclines | Reversible 30S | CA-MRSA | Moderate | Some | Rickettsia, Lyme |
| Macrolides | 50S translocation | Strep | H. influenzae | Oral | Atypical pneumonia |
| Clindamycin | 50S translocation | Strep, CA-MRSA | None | Above diaphragm | Aspiration |
| Fluoroquinolones | Gyrase, topoisomerase IV | Respiratory agents | Strong, Pseudomonas | Moxifloxacin | Pyelonephritis |
| Metronidazole | Free radicals damage DNA | None | None | Below diaphragm | Abscess |
| TMP-SMX | Folate blockade | CA-MRSA | Broad | None | UTI, PCP |

## Cell wall inhibitors are the largest tested group

Beta-lactams acylate penicillin-binding proteins and block transpeptidase cross-linking, making them bactericidal. Spectrum widens by generation: penicillin covers streptococci, syphilis and Neisseria; aminopenicillins add the **HHELPSS** organisms (H. influenzae, H. pylori, E. coli, Listeria, Proteus, Salmonella, Shigella) and enterococci; nafcillin adds penicillinase stability against MSSA; piperacillin adds Pseudomonas.

Cephalosporins climb the same ladder: first generation covers **PEcK**, second adds **HENS**, third reaches the CNS (ceftriaxone for meningitis, gonorrhea, Lyme), ceftazidime and cefepime cover Pseudomonas, and ceftaroline alone binds PBP2a and covers MRSA. Cephalosporins miss **LAME**: Listeria, Atypicals, MRSA, Enterococci.

**Vancomycin** binds the D-Ala-D-Ala precursor terminus rather than an enzyme, so beta-lactamases are irrelevant. **Bacitracin** blocks bactoprenol carrier recycling; its disc identifies *Streptococcus pyogenes*.

| Agent | Dominant resistance mechanism |
| --- | --- |
| Penicillin, ampicillin | Plasmid penicillinase cleaves the beta-lactam ring |
| Nafcillin, cephalosporins | Altered PBP2a from mecA -- this is MRSA |
| Third-generation cephalosporins | Extended-spectrum beta-lactamases |
| Carbapenems | Carbapenemases such as KPC, metallo-beta-lactamases |
| Vancomycin | D-Ala-D-Ala becomes D-Ala-D-Lac (VRE) |
| Aztreonam | Beta-lactamases; no penicillin cross-reactivity |

## Protein synthesis inhibitors split by ribosomal subunit

Use **"Buy AT 30, CCEL at 50."** The 30S drugs are **A**minoglycosides and **T**etracyclines; the 50S drugs are **C**hloramphenicol, **C**lindamycin, **E**rythromycin (macrolides) and **L**inezolid.

**Aminoglycosides** irreversibly bind 30S, block initiation and cause mRNA misreading; uptake is oxygen-dependent, so they never cover anaerobes. **Tetracyclines** reversibly block tRNA entry at the A site; doxycycline is fecally eliminated and safe in renal failure, and cations in milk, antacids and iron block absorption.

On the 50S side, **macrolides** bind 23S rRNA and block translocation, covering atypicals; resistance is 23S methylation. **Chloramphenicol** inhibits peptidyltransferase. **Clindamycin** blocks translocation and suppresses toxin production in toxic shock. **Linezolid** blocks initiation and covers MRSA and VRE.

## Nucleic acid inhibitors each carry a signature clue

**Fluoroquinolones** inhibit DNA gyrase (topoisomerase II) and topoisomerase IV. Ciprofloxacin covers gram-negatives and Pseudomonas; levofloxacin and moxifloxacin add S. pneumoniae and atypicals, and moxifloxacin covers anaerobes but is not excreted in urine, so it never treats UTI.

**Rifampin** inhibits DNA-dependent RNA polymerase -- the four R's: RNA polymerase inhibition, Ramps up P450, Red-orange body fluids, Rapid resistance as monotherapy. **Metronidazole** is reduced by anaerobes into free radicals that damage DNA, covering anaerobes below the diaphragm plus Giardia, Entamoeba and Trichomonas.

## Membrane disruptors and antimetabolites finish the list

**Polymyxins** are cationic detergents that bind LPS in the gram-negative outer membrane; colistin is last-resort for resistant gram-negatives, neurotoxic and nephrotoxic. **Daptomycin** depolarizes the gram-positive membrane -- excellent for MRSA bacteremia and VRE, but inactivated by surfactant and useless in pneumonia.

**Sulfonamides** are PABA analogs inhibiting dihydropteroate synthase; **trimethoprim** inhibits bacterial dihydrofolate reductase. Sequential blockade is bactericidal, covering uncomplicated UTI, *Pneumocystis jirovecii*, Nocardia and community-acquired MRSA.

## Toxicities are tested as often as coverage

Each drug carries a signature adverse effect the vignette telegraphs.

| Drug or class | Toxicity | Vignette clue |
| --- | --- | --- |
| Aminoglycosides | Nephrotoxicity, ototoxicity, neuromuscular blockade | Hearing loss on a loop diuretic |
| Tetracyclines | Tooth discoloration, inhibited bone growth, photosensitivity | Child with gray-brown teeth |
| Chloramphenicol | Aplastic anemia, gray baby syndrome | Ashen, hypotensive neonate |
| Fluoroquinolones | Tendinopathy and rupture, QT prolongation | Achilles pain on steroids |
| Metronidazole | Disulfiram-like reaction, metallic taste | Vomiting after alcohol |
| Vancomycin | Infusion reaction with flushing, nephrotoxicity | Flushing during rapid infusion |
| Linezolid | Serotonin syndrome, thrombocytopenia, optic neuropathy | Falling platelets on an SSRI |
| TMP-SMX | Hyperkalemia, sulfa allergy, megaloblastic anemia | Potassium rises during UTI therapy |

Several overlap with [high-yield drug side effects](/blog/high-yield-drug-side-effects-usmle).

## A coverage cheat sheet beats a drug-by-drug list

Four coverage groups answer most questions.

- **MRSA:** vancomycin, daptomycin, linezolid, ceftaroline; outpatient, TMP-SMX or doxycycline.
- **Pseudomonas:** piperacillin-tazobactam, ceftazidime, cefepime, meropenem (never ertapenem), aztreonam, ciprofloxacin.
- **Anaerobes above the diaphragm:** clindamycin. **Below:** metronidazole. Both: piperacillin-tazobactam, carbapenems, cefoxitin, cefotetan.
- **Atypicals** (Mycoplasma, Chlamydia, Legionella): macrolides, doxycycline, respiratory fluoroquinolones -- never a beta-lactam: Mycoplasma has no wall and the rest are intracellular.

> **10-second exam strategy:** name the organism, ask whether it has a wall to attack, then whether the drug reaches the site. Vancomycin never treats gram-negatives, aminoglycosides never treat anaerobes, daptomycin never treats pneumonia.

## Antibiotic selection on a vignette follows four steps

Work the stem in order.

1. **Identify the organism class** from the gram stain, culture, or epidemiologic clue: tick bite, aspiration, hardware, neutropenia -- the [Infectious Disease](/topics/infectious-disease) hub indexes them.
2. **Match the spectrum** narrowly; broad empiric therapy is right only before cultures return.
3. **Check the site.** Ceftriaxone, vancomycin, ampicillin and meropenem enter the CNS; first-generation cephalosporins and aminoglycosides do not; nitrofurantoin works only in urine.
4. **Apply the population rule** for pregnancy, allergy or renal function.

## Special populations change the answer more often than the organism does

**Pregnancy:** penicillins, cephalosporins, aztreonam, azithromycin and clindamycin are safe. Avoid tetracyclines, fluoroquinolones, aminoglycosides, chloramphenicol and TMP-SMX, which risks neural tube defects early and kernicterus at term.

**Penicillin allergy:** cross-reactivity with cephalosporins is low and driven by shared R1 side chains, highest with first-generation agents. For anaphylaxis choose a non-beta-lactam -- a macrolide or clindamycin for strep pharyngitis, vancomycin for gram-positives, aztreonam for gram-negatives. Pregnant patients with syphilis are desensitized and still given penicillin.

**Renal impairment:** most beta-lactams, vancomycin, aminoglycosides and fluoroquinolones need dose adjustment. Ceftriaxone, azithromycin, doxycycline, clindamycin and linezolid clear hepatically or biliary and do not.

## How this is tested on the exam

- **Stem:** MRSA pneumonia on daptomycin fails to improve. **Answer:** surfactant inactivates daptomycin; switch to vancomycin or linezolid.
- **Stem:** an adult over 60 with meningitis on ceftriaxone and vancomycin. **Answer:** add ampicillin for Listeria, which cephalosporins never cover.
- **Stem:** orange tears and urine on four-drug tuberculosis therapy. **Answer:** rifampin; reassure and continue.

## Common wrong-answer traps

- **Adding a beta-lactamase inhibitor for MRSA.** MRSA resistance is an altered target, PBP2a, not an enzyme, so clavulanate adds nothing.
- **Using an aminoglycoside against an anaerobe.** Uptake requires oxygen, so anaerobes are intrinsically resistant.
- **Choosing ertapenem for Pseudomonas.** Ertapenem is the carbapenem lacking antipseudomonal activity.
- **Calling vancomycin flushing an allergy.** That reaction is histamine release; slow the infusion.

## Sources

- [CDC: Antibiotic Use](https://www.cdc.gov/antibiotic-use/)
- [IDSA Practice Guidelines](https://www.idsociety.org/practice-guideline/practice-guidelines/)
- [USMLE Step 1](https://www.usmle.org/step-exams/step-1)

Antibiotic pharmacology fades fast. [Drill antibiotic pharmacology with StepGenie flashcards](https://dashboard.stepgenie.app/sign-up) so mechanism, coverage and toxicity return automatically on exam day.

## Frequently asked questions

### Which antibiotics are bactericidal and which are bacteriostatic?

Bactericidal antibiotics kill organisms outright: beta-lactams, vancomycin, aminoglycosides, fluoroquinolones, metronidazole, daptomycin and rifampin. Bacteriostatic antibiotics only halt replication and rely on the immune system: macrolides, clindamycin, tetracyclines, chloramphenicol, linezolid and sulfonamides used alone. The distinction matters on the exam for endocarditis, meningitis and neutropenic patients, where a bactericidal drug is preferred because host defenses cannot finish the job.

### Which antibiotics cover MRSA?

For serious or hospital-acquired MRSA, use vancomycin, daptomycin, linezolid or ceftaroline, the only cephalosporin that binds the altered PBP2a target. For community-acquired MRSA skin infection, oral trimethoprim-sulfamethoxazole, doxycycline or clindamycin are appropriate. Remember that daptomycin is inactivated by pulmonary surfactant, so it never treats MRSA pneumonia, and that adding a beta-lactamase inhibitor does nothing because MRSA resistance is target alteration, not enzyme production.

### Why do aminoglycosides not cover anaerobes?

Aminoglycosides enter bacteria through an oxygen-dependent transport system, so organisms growing without oxygen never take the drug up and are intrinsically resistant. That is why an aminoglycoside is never the answer for an intra-abdominal abscess, aspiration pneumonia or Bacteroides fragilis. Aminoglycosides are instead paired with a cell wall agent against aerobic gram-negative rods, where the beta-lactam damages the wall and improves aminoglycoside uptake.

### Which antibiotics are safe in pregnancy?

Penicillins, cephalosporins, aztreonam, azithromycin and clindamycin are the safe backbone in pregnancy. Avoid tetracyclines, which stain fetal teeth and impair bone growth; fluoroquinolones, which damage cartilage; aminoglycosides, which are ototoxic to the fetus; chloramphenicol, which causes gray baby syndrome; and trimethoprim-sulfamethoxazole, which risks neural tube defects early and kernicterus at term. Syphilis in pregnancy is treated with penicillin after desensitization.

### What does the mnemonic buy AT 30 CCEL at 50 mean?

The mnemonic sorts protein synthesis inhibitors by ribosomal subunit. At the 30S subunit sit Aminoglycosides, which bind irreversibly and cause messenger RNA misreading, and Tetracyclines, which reversibly block transfer RNA entry at the A site. At the 50S subunit sit Chloramphenicol, Clindamycin, Erythromycin and the other macrolides, and Linezolid. Knowing the subunit predicts the resistance mechanism and often the toxicity.

---

Canonical page: [Antibiotic Mechanisms & Coverage (USMLE)](https://www.stepgenie.app/blog/antibiotic-mechanisms-coverage-usmle)
Topic hub: [Infectious Disease](https://www.stepgenie.app/topics/infectious-disease)